Cassava sciences to present at the h.c. wainwright global investment conference

Austin, texas, sept. 08, 2022 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, announced today that it has been invited to present a corporate overview at the h.c. wainwright 24th annual global investment conference, being held in new york.
SAVA Ratings Summary
SAVA Quant Ranking